Induction Agents for Tracheal Intubation in Critically Ill Patients

Area of Science:

• Critical care medicine
• Pharmacology
• Emergency medicine

Background:

• Tracheal intubation is a common procedure in critically ill patients.
• Selection of appropriate induction agents is crucial for patient outcomes.
• Existing evidence on induction agents in critical care is evolving.

Purpose of the Study:

• To review the use of induction agents in critically ill patients undergoing tracheal intubation.
• To analyze the association between induction agents and patient outcomes.
• To provide evidence-based recommendations for drug selection.

Main Methods:

• Comprehensive PubMed search for original publications on induction agents for tracheal intubation in critically ill patients.
• Inclusion of randomized controlled trials and observational studies reporting patient outcomes.
• Extraction of data on induction agent choice and clinically relevant outcomes.

Main Results:

• Etomidate and ketamine are the most studied agents; etomidate may increase mortality without clear hemodynamic benefits over ketamine.
• Propofol is associated with post-intubation cardiovascular instability in observational data, warranting caution.
• Ketamine demonstrates a favorable safety profile compared to etomidate and propofol.

Conclusions:

• Current evidence suggests ketamine may be the preferred induction agent due to its safety profile, availability, and cost.
• Etomidate's potential negative impact on survival and propofol's association with cardiovascular instability require consideration.
• Future research should focus on definitive data for optimal drug selection, dosing, and minimizing peri-intubation complications.